Amlodipine 10mg Drug Use Investigation (ENTER10)

Viatris

Status: Completed

Conditions: Hypertension

Treatments: Drug: Amlodipine

Study type: Observational

Funder types: Industry

Identifiers

NCT01252563

A0531097

Details and patient eligibility

About

In this survey, to collect the safety and efficacy information in the subjects who have been treated with amlodipine 5mg at least 4 weeks in daily practice.

Full description

All the subjects whom an investigator prescribes Amlodipine (Norvasc®) 10mg Tablet should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 14,141 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female subjects who have been treated with amlodipine 5mg at least 4 weeks
• The subjects who had not achieved target BP

Exclusion criteria

• Subjects who have been prescribed amlodipine (Norvasc®) 10mg Tablet before

Trial design

14,141 participants in 1 patient group

Amlodipine 10mg Tablet

Description:

Subjects taking Amlodipine 10mg Tablet.

Treatment:

Drug: Amlodipine